We found that, while downregulation of NR2F1 limits the extravasation ability of tumor cells by ~10%, still ~25% of the DTCs with knockdown are able to extravasate, suggesting a minor role for NR2F1 on this step (Supplementary Fig. 5e). This evidence concerns the gene NR2F1 and neoplasm.